NSG 520 EXAM 1 PHARMACOLOGY AND
PATHOPHYSIOLOGY MODULES 1–4 | LATEST
2026 VERIFIED QUESTIONS & ANSWERS |
ADVANCED PRACTICE NURSING EXAM PREP
| 100% CORRECT ANSWERS | A+ STUDY
GUIDE & REVIEW BUNDLE
• This 214-question exam prep bundle covers NSG 520 Pharmacology and
Pathophysiology (Modules 1–4) at the advanced practice nursing level, featuring
verified questions with highlighted correct answers and detailed EXPERT
RATIONALE for every item.
• Work through each question independently before checking the answer — use
the EXPERT RATIONALE to reinforce understanding, not just memorize correct
choices, and revisit any question you answered incorrectly at least twice before
your exam date.
NSG 520 EXAM 1 — PHARMACOLOGY AND PATHOPHYSIOLOGY MODULES 1–4 |
ADVANCED PRACTICE NURSING | 214 QUESTIONS
QUESTION 1
Which of the following best describes the term "pharmacodynamics"?
A. The study of how drugs are absorbed, distributed, metabolized, and excreted
B. The study of how genetic factors affect drug response
C. The study of how drugs interact with receptors to produce a biological effect
D. The study of adverse drug reactions in clinical populations
E. The study of drug formulation and manufacturing
CORRECT ANSWER: C. The study of how drugs interact with receptors to
produce a biological effect
EXPERT RATIONALE: Pharmacodynamics refers to the biochemical and physiological
effects of drugs on the body and their mechanisms of action, including receptor binding
,and resultant biological responses. Pharmacokinetics, by contrast, describes what the
body does to the drug (absorption, distribution, metabolism, excretion).
QUESTION 2
A drug that binds to a receptor and produces a maximal biological response is
best classified as:
A. A partial agonist
B. An antagonist
C. An inverse agonist
D. A full agonist
E. A allosteric modulator
CORRECT ANSWER: D. A full agonist
EXPERT RATIONALE: A full agonist binds to a receptor and produces the maximum
possible response (Emax). A partial agonist produces a submaximal response even at full
receptor occupancy. An antagonist blocks receptor activity without producing a
response.
QUESTION 3
Which pharmacokinetic process refers to the fraction of an administered drug
that reaches systemic circulation unchanged?
A. First-pass metabolism
B. Bioavailability
C. Volume of distribution
D. Protein binding
E. Renal clearance
CORRECT ANSWER: B. Bioavailability
,EXPERT RATIONALE: Bioavailability (F) is the proportion of a drug dose that reaches
systemic circulation in an active form. Intravenous drugs have 100% bioavailability. Oral
drugs may have reduced bioavailability due to first-pass hepatic metabolism and
incomplete gastrointestinal absorption.
QUESTION 4
A patient is prescribed a drug with a narrow therapeutic index. As an APRN,
your priority concern is:
A. Ensuring the drug is taken with food
B. Monitoring plasma drug levels and signs of toxicity closely
C. Encouraging the patient to take double doses if one is missed
D. Switching to a drug with a wider therapeutic index immediately
E. Administering the drug via intramuscular route only
CORRECT ANSWER: B. Monitoring plasma drug levels and signs of toxicity
closely
EXPERT RATIONALE: A narrow therapeutic index means the difference between the
effective dose and the toxic dose is small. Close monitoring of serum drug levels and
clinical signs of toxicity is essential to prevent adverse outcomes. Examples include
warfarin, digoxin, lithium, and aminoglycosides.
QUESTION 5
The volume of distribution (Vd) of a drug is best described as:
A. The rate at which a drug is eliminated from the body
B. A measure of how extensively a drug distributes into body tissues relative to
plasma
C. The total amount of drug absorbed after oral administration
D. The hepatic extraction ratio of a drug
, E. The fraction of drug that is protein-bound in plasma
CORRECT ANSWER: B. A measure of how extensively a drug distributes into
body tissues relative to plasma
EXPERT RATIONALE: Vd is a theoretical volume that relates the total amount of drug in
the body to its plasma concentration. A large Vd indicates extensive tissue distribution; a
small Vd suggests the drug remains largely in the plasma compartment.
QUESTION 6
Which cytochrome P450 enzyme is responsible for metabolizing the largest
number of clinically used drugs?
A. CYP1A2
B. CYP2D6
C. CYP3A4
D. CYP2C9
E. CYP2E1
CORRECT ANSWER: C. CYP3A4
EXPERT RATIONALE: CYP3A4 is the most abundant hepatic CYP enzyme and metabolizes
approximately 50% of all clinically used drugs. It is subject to induction and inhibition by
many common drugs and foods, including grapefruit juice, making it clinically significant
for drug interactions.
QUESTION 7
First-pass metabolism is most relevant when a drug is administered via which
route?
A. Intravenous
B. Sublingual
PATHOPHYSIOLOGY MODULES 1–4 | LATEST
2026 VERIFIED QUESTIONS & ANSWERS |
ADVANCED PRACTICE NURSING EXAM PREP
| 100% CORRECT ANSWERS | A+ STUDY
GUIDE & REVIEW BUNDLE
• This 214-question exam prep bundle covers NSG 520 Pharmacology and
Pathophysiology (Modules 1–4) at the advanced practice nursing level, featuring
verified questions with highlighted correct answers and detailed EXPERT
RATIONALE for every item.
• Work through each question independently before checking the answer — use
the EXPERT RATIONALE to reinforce understanding, not just memorize correct
choices, and revisit any question you answered incorrectly at least twice before
your exam date.
NSG 520 EXAM 1 — PHARMACOLOGY AND PATHOPHYSIOLOGY MODULES 1–4 |
ADVANCED PRACTICE NURSING | 214 QUESTIONS
QUESTION 1
Which of the following best describes the term "pharmacodynamics"?
A. The study of how drugs are absorbed, distributed, metabolized, and excreted
B. The study of how genetic factors affect drug response
C. The study of how drugs interact with receptors to produce a biological effect
D. The study of adverse drug reactions in clinical populations
E. The study of drug formulation and manufacturing
CORRECT ANSWER: C. The study of how drugs interact with receptors to
produce a biological effect
EXPERT RATIONALE: Pharmacodynamics refers to the biochemical and physiological
effects of drugs on the body and their mechanisms of action, including receptor binding
,and resultant biological responses. Pharmacokinetics, by contrast, describes what the
body does to the drug (absorption, distribution, metabolism, excretion).
QUESTION 2
A drug that binds to a receptor and produces a maximal biological response is
best classified as:
A. A partial agonist
B. An antagonist
C. An inverse agonist
D. A full agonist
E. A allosteric modulator
CORRECT ANSWER: D. A full agonist
EXPERT RATIONALE: A full agonist binds to a receptor and produces the maximum
possible response (Emax). A partial agonist produces a submaximal response even at full
receptor occupancy. An antagonist blocks receptor activity without producing a
response.
QUESTION 3
Which pharmacokinetic process refers to the fraction of an administered drug
that reaches systemic circulation unchanged?
A. First-pass metabolism
B. Bioavailability
C. Volume of distribution
D. Protein binding
E. Renal clearance
CORRECT ANSWER: B. Bioavailability
,EXPERT RATIONALE: Bioavailability (F) is the proportion of a drug dose that reaches
systemic circulation in an active form. Intravenous drugs have 100% bioavailability. Oral
drugs may have reduced bioavailability due to first-pass hepatic metabolism and
incomplete gastrointestinal absorption.
QUESTION 4
A patient is prescribed a drug with a narrow therapeutic index. As an APRN,
your priority concern is:
A. Ensuring the drug is taken with food
B. Monitoring plasma drug levels and signs of toxicity closely
C. Encouraging the patient to take double doses if one is missed
D. Switching to a drug with a wider therapeutic index immediately
E. Administering the drug via intramuscular route only
CORRECT ANSWER: B. Monitoring plasma drug levels and signs of toxicity
closely
EXPERT RATIONALE: A narrow therapeutic index means the difference between the
effective dose and the toxic dose is small. Close monitoring of serum drug levels and
clinical signs of toxicity is essential to prevent adverse outcomes. Examples include
warfarin, digoxin, lithium, and aminoglycosides.
QUESTION 5
The volume of distribution (Vd) of a drug is best described as:
A. The rate at which a drug is eliminated from the body
B. A measure of how extensively a drug distributes into body tissues relative to
plasma
C. The total amount of drug absorbed after oral administration
D. The hepatic extraction ratio of a drug
, E. The fraction of drug that is protein-bound in plasma
CORRECT ANSWER: B. A measure of how extensively a drug distributes into
body tissues relative to plasma
EXPERT RATIONALE: Vd is a theoretical volume that relates the total amount of drug in
the body to its plasma concentration. A large Vd indicates extensive tissue distribution; a
small Vd suggests the drug remains largely in the plasma compartment.
QUESTION 6
Which cytochrome P450 enzyme is responsible for metabolizing the largest
number of clinically used drugs?
A. CYP1A2
B. CYP2D6
C. CYP3A4
D. CYP2C9
E. CYP2E1
CORRECT ANSWER: C. CYP3A4
EXPERT RATIONALE: CYP3A4 is the most abundant hepatic CYP enzyme and metabolizes
approximately 50% of all clinically used drugs. It is subject to induction and inhibition by
many common drugs and foods, including grapefruit juice, making it clinically significant
for drug interactions.
QUESTION 7
First-pass metabolism is most relevant when a drug is administered via which
route?
A. Intravenous
B. Sublingual
